Beta Finch - Colgate-Palmolive - CL - EN

**BETA FINCH PODCAST SCRIPT****ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the latest quarterly results and what they mean for investors. I'm Alex.**JORDAN**: And I'm Jordan. Today we're breaking down Colgate-Palmolive's Q1 2026 earnings call, and there's quite a bit to unpack here.**ALEX**: Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.**JORDAN**: Absolutely. Now, Alex, Colgate had an interesting quarter - some really strong performance in certain areas, but they're also dealing with significant headwinds. Where do you want to start?**ALEX**: Let's kick off with the headline numbers. Colgate delivered what CEO Noel Wallace called "strong top and bottom line growth" with organic sales growth actually accelerating from Q4. They saw growth in both volume and pricing across all four categories and four of five divisions, which is pretty impressive breadth.**JORDAN**: That's right, and what really caught my attention was the geographic mix. Emerging markets were the star of the show, particularly Asia Pacific. Wallace mentioned that these are regions where Colgate's global brands have higher market shares and greater scale advantages, so they're doubling down on investments there.**ALEX**: Speaking of investments, they're maintaining their focus on brand equity and advertising spending, which is notable given the cost pressures they're facing. But Jordan, let's talk about the elephant in the room - that $300 million increase in expected raw material and logistics costs.**JORDAN**: Yeah, this is where things get interesting from a margins perspective. They had to revise their gross margin outlook downward because of these cost pressures. CFO Stanley Sutula broke it down - about two-thirds of that $300 million hit is from raw materials, one-third from logistics. The big culprits? Oil byproducts like resins and petrochemicals, with spending in those areas expected to be up more than 20% year-over-year.**ALEX**: And they're assuming crude oil at around $110 for their planning purposes. But here's what I found encouraging - despite these headwinds, they reaffirmed their full-year guidance for both top and bottom line growth. How are they managing to do that?**JORDAN**: It comes down to what Wallace calls their "flexible P&L model." They're offsetting these cost pressures through several levers: revenue growth management, or RGM, productivity initiatives, and they just announced an acceleration of their Strategic Growth and Productivity Program - or SGPP.**ALEX**: Let's dig into that SGPP announcement because it's pretty significant. They're now targeting $200 million to $300 million in annualized savings, with most of those savings hitting in 2027 and 2028. Wallace emphasized this isn't an extension of the program - it's still completing by end of 2028 - but they've identified additional opportunities.**JORDAN**: Right, and Sutula explained that the strong execution from their teams allowed them to reach the high end of their initial targets, plus they found new ways to simplify operations and enhance efficiency. I like that they're being proactive about organizational structure and reducing complexity.**ALEX**: Now, the regional performance was really telling. Asia Pacific was a standout, with improvements in both China through their Hawley & Hazel business and strong performance in India. Wallace mentioned they're not "completely out of the woods" in China yet, but the interventions they've made - accelerated innovation, better omnichannel execution - are starting to pay off.**JORDAN**: Latin America also had another strong volume quarter with mid-single-digit growth. Wallace was particularly enthusiastThis episode includes AI-generated content.

**BETA FINCH PODCAST SCRIPT**---**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Colgate-Palmolive's Q4 2025 results. Now, before we get into the toothpaste and pet food numbers, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.**JORDAN**: Thanks Alex. And speaking of brushing up on the details, Colgate just wrapped up what CEO Noel Wallace called a "stronger-than-expected Q4" despite some pretty challenging headwinds. The big story here isn't just the quarter though - it's their new 2030 strategy they're launching.**ALEX**: Right, so let's start with the numbers. What stood out to you from the quarter?**JORDAN**: Well, the momentum story is compelling. They saw sequential improvement in organic sales growth across most regions - hitting over 3% organic growth when you exclude their planned exit from private label business. That's a nice acceleration from Q3. And importantly, they delivered modest volume growth in Q4, which is no small feat in this environment.**ALEX**: And the cash flow performance was pretty impressive too, right?**JORDAN**: Absolutely stellar - record operating cash flow of $4.2 billion. That's giving them serious flexibility for reinvestment and potential acquisitions. Wallace kept emphasizing this "flexibility" theme throughout the call.**ALEX**: Now, the guidance for 2026 was interesting - they gave a pretty wide range of 1% to 4% for organic sales growth. That's unusually broad for Colgate.**JORDAN**: Yeah, and Wallace was refreshingly transparent about why. He basically said: if categories get worse, they'll be at the low end. If categories stay where they are, they'll be in the middle. If categories strengthen, they hope to hit the higher end. It's a simple framework, but it shows just how uncertain they feel about the consumer environment right now.**ALEX**: Speaking of uncertainty, the U.S. market seems to be their biggest challenge. What's happening there?**JORDAN**: It's pretty stark. Wallace mentioned that nine of their categories were down in volume in October, ten in November. The North American business is clearly struggling with what he called "consumer uncertainty." People are holding back on filling their pantries, buying more on promotion, and there's this general sluggishness in category growth.**ALEX**: But there were some bright spots internationally, weren't there?**JORDAN**: Definitely. Latin America had a really strong quarter - both Mexico and Brazil growing high single digits. And their emerging markets overall grew about 4.5% organically with good balance between price and volume. It's that classic story of developed markets struggling while emerging markets show more resilience.**ALEX**: The Hill's pet food business also seemed to perform well despite a tough category backdrop.**JORDAN**: Hill's was a standout - over 5% growth excluding private label, with positive volume growth. Their prescription diet business is really driving growth, and that higher-margin therapeutic segment is exactly where you want to see momentum. Wallace mentioned they're gaining share across all channels.**ALEX**: Now, let's talk about this 2030 strategy they unveiled. It sounds like a pretty significant shift.**JORDAN**: It's fascinating - they're basically reorganizing around what they call "omnichannel demand generation." Instead of having separate e-commerce and brick-and-mortar teams, they're creating one integrated commercial organization. Wallace said they've been sending leaders to China to learn from their team there, which has figured out how to excel in both traditional retail and online.**ALEX**: And they're backing this up with their StThis episode includes AI-generated content.

Stay tuned for AI-powered earnings analysis from Beta Finch.This episode includes AI-generated content.